Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tether Investments is the strategic venture and development arm of the Tether Group, focused on scaling disruptive technologies at the intersection of infrastructure and human potential. The firm gained global prominence in the life sciences sector in 2024 by acquiring a majority stake in Blackrock Neurotech, a leading pioneer in high-bandwidth brain-computer interface (BCI) technology designed to restore mobility and communication for patients with paralysis. Beyond its investment portfolio, Tether has expanded into direct health technology with the launch of the QVAC Health app, a privacy-focused wellness tracking platform that utilizes on-device AI to process sensitive health data locally. Based in El Salvador, the company leverages substantial capital reserves from the Tether ecosystem to foster innovation in robotics, neurotechnology, and decentralized digital health. Tether Investments operates under the leadership of CEO Paolo Ardoino and manages a diverse portfolio that bridges the gap between digital asset infrastructure and transformative biomedical engineering.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tether Investments.